200 related articles for article (PubMed ID: 31714356)
1. Global status of Toxoplasma gondii infection and associated risk factors in people living with HIV.
Safarpour H; Cevik M; Zarean M; Barac A; Hatam-Nahavandi K; Rahimi MT; Bannazadeh Baghi H; Koshki TJ; Pagheh AS; Shahrivar F; Ebrahimi M; Ahmadpour E
AIDS; 2020 Mar; 34(3):469-474. PubMed ID: 31714356
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of Toxoplasma gondii in the Iranian pregnant women: A systematic review and meta-analysis.
Foroutan-Rad M; Khademvatan S; Majidiani H; Aryamand S; Rahim F; Malehi AS
Acta Trop; 2016 Jun; 158():160-169. PubMed ID: 26952970
[TBL] [Abstract][Full Text] [Related]
3. Difference in
Yenilmez E; Çetinkaya RA
Turkiye Parazitol Derg; 2019 Oct; 43(Suppl 1):1-7. PubMed ID: 31587535
[TBL] [Abstract][Full Text] [Related]
4. Investigating the risk factors for seroprevalence and the correlation between CD4+ T-cell count and humoral antibody responses to Toxoplasma gondii infection amongst HIV patients in the Bamenda Health District, Cameroon.
Fang EE; Nyasa RB; Ndi EM; Zofou D; Kwenti TE; Lepezeu EP; Titanji VPK; N Ndip R
PLoS One; 2021; 16(12):e0256947. PubMed ID: 34855762
[TBL] [Abstract][Full Text] [Related]
5. Potential risk factors associated with seropositivity for Toxoplasma gondii among pregnant women and HIV infected individuals in Ethiopia: A systematic review and meta-analysis.
Tarekegn ZS; Dejene H; Addisu A; Dagnachew S
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008944. PubMed ID: 33320848
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risk factors in women of child-bearing age in Njinikom, NW Cameroon.
Wam EC; Sama LF; Ali IM; Ebile WA; Aghangu LA; Tume CB
BMC Res Notes; 2016 Aug; 9(1):406. PubMed ID: 27528009
[TBL] [Abstract][Full Text] [Related]
7. Serological Evaluation of Toxoplasmosis and Related Risk Factors Among HIV
Rafati-Sajedi H; Majidi-Shad B; Jafari-Shakib R; Atrkar-Roshan Z; Mahmoudi MR; Rezvani SM
Acta Parasitol; 2021 Dec; 66(4):1417-1423. PubMed ID: 34021879
[TBL] [Abstract][Full Text] [Related]
8. Global Burden of
Ramezanzadeh S; Beloukas A; Pagheh AS; Rahimi MT; Hosseini SA; Oliveira SMR; de Lourdes Pereira M; Ahmadpour E
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746750
[No Abstract] [Full Text] [Related]
9. Elevated seroprevalence of Toxoplasma gondii in AIDS/HIV patients: A meta-analysis.
Liu L; Liu LN; Wang P; Lv TT; Fan YG; Pan HF
Acta Trop; 2017 Dec; 176():162-167. PubMed ID: 28784422
[TBL] [Abstract][Full Text] [Related]
10. Risk factors associated with seropositivity for Toxoplasma gondii in population-based studies among immunocompromised patients (pregnant women, HIV patients and children) in West African countries, Cameroon and Gabon: a meta-analysis.
Odeniran PO; Omolabi KF; Ademola IO
Acta Trop; 2020 Sep; 209():105544. PubMed ID: 32461111
[TBL] [Abstract][Full Text] [Related]
11. The global seroprevalence of Toxoplasma gondii in pigs: A systematic review and meta-analysis.
Foroutan M; Fakhri Y; Riahi SM; Ebrahimpour S; Namroodi S; Taghipour A; Spotin A; Gamble HR; Rostami A
Vet Parasitol; 2019 May; 269():42-52. PubMed ID: 31079827
[TBL] [Abstract][Full Text] [Related]
12. [Seroprevalence and risk factors of
Xie YQ; He MZ; Zhang WH
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2020 Jul; 32(6):635-639. PubMed ID: 33325201
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of Toxoplasma gondii Infection among HIV/AIDS Patients in Eastern China.
Shen G; Wang X; Sun H; Gao Y
Korean J Parasitol; 2016 Feb; 54(1):93-6. PubMed ID: 26951986
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and burden of Toxoplasma gondii infection in HIV-infected people: a systematic review and meta-analysis.
Wang ZD; Wang SC; Liu HH; Ma HY; Li ZY; Wei F; Zhu XQ; Liu Q
Lancet HIV; 2017 Apr; 4(4):e177-e188. PubMed ID: 28159548
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence and associated risk factors of Toxoplasma gondii among Manchu pregnant women in northeastern China.
Jiang RL; Ma LH; Ma ZR; Hou G; Zhao Q; Wu X
Microb Pathog; 2018 Oct; 123():398-401. PubMed ID: 30063975
[TBL] [Abstract][Full Text] [Related]
16. Human Toxoplasma gondii infection in Nigeria: a systematic review and meta-analysis of data published between 1960 and 2019.
Karshima SN; Karshima MN
BMC Public Health; 2020 Jun; 20(1):877. PubMed ID: 32505179
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence and risk factors of Toxoplasma gondii infection among healthy blood donors in south-east of Iran.
Mahmoudvand H; Saedi Dezaki E; Soleimani S; Baneshi MR; Kheirandish F; Ezatpour B; Zia-Ali N
Parasite Immunol; 2015 Jul; 37(7):362-7. PubMed ID: 25891186
[TBL] [Abstract][Full Text] [Related]
18. Association of Toxoplasma gondii infection with cardiovascular diseases: a cross-sectional study among patients with heart failure diseases in Urmia, North-West of Iran.
Khademvatan S; Khademvatani K; Tappeh KH; Asadi N; Khezri P; Abasi E
Ann Parasitol; 2020; 66(2):193-199. PubMed ID: 32592458
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of
Shakib P; Behzadifar M; Mahmoudvand H; Larki S; Kalani H; Zivdari M; Mardanshah O; Cheraghipour K
Curr HIV Res; 2023; 21(4):221-231. PubMed ID: 37873950
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and predictors of Toxoplasma gondii infection in pregnant women from Dhamar, Yemen.
Al-Adhroey AH; Mehrass AAO; Al-Shammakh AA; Ali AD; Akabat MYM; Al-Mekhlafi HM
BMC Infect Dis; 2019 Dec; 19(1):1089. PubMed ID: 31888517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
